These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31870215)

  • 1. Quantitative structure-activity relationships analysis, homology modeling, docking and molecular dynamics studies of triterpenoid saponins as Kirsten rat sarcoma inhibitors.
    Stitou M; Toufik H; Bouachrine M; Lamchouri F
    J Biomol Struct Dyn; 2021 Jan; 39(1):152-170. PubMed ID: 31870215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational investigation of imidazo[2,1-b]oxazole derivatives as potential mutant BRAF kinase inhibitors: 3D-QSAR, molecular docking, molecular dynamics simulation, and ADMETox studies.
    Boutalaka M; El Bahi S; Alaqarbeh M; El Alaouy MA; Koubi Y; Khatabi KE; Maghat H; Bouachrine M; Lakhlifi T
    J Biomol Struct Dyn; 2024 Jul; 42(10):5268-5287. PubMed ID: 37424193
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Shirvani P; Fassihi A
    J Biomol Struct Dyn; 2022 Aug; 40(13):5965-5982. PubMed ID: 33475043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico studies on p21-activated kinase 4 inhibitors: comprehensive application of 3D-QSAR analysis, molecular docking, molecular dynamics simulations, and MM-GBSA calculation.
    Gao Y; Wang H; Wang J; Cheng M
    J Biomol Struct Dyn; 2020 Sep; 38(14):4119-4133. PubMed ID: 31556340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel monoamine oxidase B (MAO-B) inhibitors by combined application of docking-based alignment, 3D-QSAR, ADMET prediction, molecular dynamics simulation, and MM_GBSA binding free energy.
    El Aissouq A; Chedadi O; Bouachrine M; Ouammou A; Khalil F
    J Biomol Struct Dyn; 2023 Jul; 41(10):4667-4680. PubMed ID: 35510607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico discovery of potent and selective Janus kinase 3 (JAK3) inhibitors through 3D-QSAR, covalent docking, ADMET analysis, molecular dynamics simulations, and binding free energy of pyrazolopyrimidine derivatives.
    Faris A; Hadni H; Ibrahim IM; Elhallaoui M
    J Biomol Struct Dyn; 2024 Jun; 42(9):4817-4833. PubMed ID: 37338041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the binding mechanism of piperidinyl ureas inhibitors based on the UBC12-DCN1 interaction by 3D-QSAR, molecular docking and molecular dynamics simulations.
    Zhao J; Zang J; Yang J; Gao QB; Yan Y; Ma C; Chen Y; Ding L; Liu HM
    J Biomol Struct Dyn; 2022 Apr; 40(6):2674-2688. PubMed ID: 33183176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of novel DABO derivatives as HIV-1 RT inhibitors using molecular docking, molecular dynamics simulations and ADMET properties.
    Zhang Y; Chen L; Wang Z; Zhu Y; Jiang H; Xu J; Xiong F
    J Biomol Struct Dyn; 2024 May; 42(8):4196-4213. PubMed ID: 37272892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual screening of PEBP1 inhibitors by combining 2D/3D-QSAR analysis, hologram QSAR, homology modeling, molecular docking analysis, and molecular dynamic simulations.
    Stitou M; Toufik H; Akabli T; Lamchouri F
    J Mol Model; 2022 May; 28(6):145. PubMed ID: 35545728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the binding mechanism of substituted pyridine derivatives as effective and selective lysine-specific demethylase 1 inhibitors using 3D-QSAR, molecular docking and molecular dynamics simulations.
    Wang ZZ; Yang J; Sun XD; Ma CY; Gao QB; Ding L; Liu HM
    J Biomol Struct Dyn; 2019 Aug; 37(13):3482-3495. PubMed ID: 30175693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D-QSAR, molecular dynamics simulations and molecular docking studies of benzoxazepine moiety as mTOR inhibitor for the treatment of lung cancer.
    Chaube U; Chhatbar D; Bhatt H
    Bioorg Med Chem Lett; 2016 Feb; 26(3):864-874. PubMed ID: 26764189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational investigation of imidazopyridine analogs as protein kinase B (Akt1) allosteric inhibitors by using 3D-QSAR, molecular docking and molecular dynamics simulations.
    Gu X; Wang Y; Wang M; Wang J; Li N
    J Biomol Struct Dyn; 2021 Jan; 39(1):63-78. PubMed ID: 31838955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docking-based 3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) study on hydroquinoline and thiazinan-4-one derivatives as selective COX-2 inhibitors.
    Dowlati Beirami A; Hajimahdi Z; Zarghi A
    J Biomol Struct Dyn; 2019 Jul; 37(11):2999-3006. PubMed ID: 30035675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer.
    Chhatbar DM; Chaube UJ; Vyas VK; Bhatt HG
    Comput Biol Chem; 2019 Jun; 80():351-363. PubMed ID: 31085426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations of retinoic acid receptor-related orphan receptor-gamma t (RORĪ³t) agonists: a combination of 3D-QSAR, molecular docking and molecular dynamics.
    Chen Q; Wang F; Zhou B
    J Biomol Struct Dyn; 2021 Jul; 39(10):3501-3514. PubMed ID: 32375589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modeling study of pyrrolidine derivatives as novel myeloid cell leukemia-1 inhibitors through combined 3D-QSAR, molecular docking, ADME/Tox and MD simulation techniques.
    Tabti K; Baammi S; Sbai A; Maghat H; Lakhlifi T; Bouachrine M
    J Biomol Struct Dyn; 2023; 41(23):13798-13814. PubMed ID: 36841617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into the interaction mechanism of human SGLT2 with its inhibitors: 3D-QSAR studies, homology modeling, and molecular docking and molecular dynamics simulations.
    Dong L; Feng R; Bi J; Shen S; Lu H; Zhang J
    J Mol Model; 2018 Mar; 24(4):86. PubMed ID: 29511885
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Akabli T; Toufik H; Lamchouri F
    J Biomol Struct Dyn; 2022 Jun; 40(9):3965-3978. PubMed ID: 33252029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modeling-driven approach for identification of Janus kinase 1 inhibitors through 3D-QSAR, docking and molecular dynamics simulations.
    Itteboina R; Ballu S; Sivan SK; Manga V
    J Recept Signal Transduct Res; 2017 Oct; 37(5):453-469. PubMed ID: 28537140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.